by John R. Fischer
, Senior Reporter | March 14, 2022
ZAP Surgical Systems is installing two of its Gyroscopic Radiosurgery systems at Apollo Hospitals Enterprise in India for complete noninvasive brain tumor treatments.
The solution is designed to provide stereotactic radiosurgery, a noninvasive procedure that often provides equivalent to superior outcomes for invasive surgical operations, but requires no incision and little to no patient recovery period.
The hospitals will be the first in the country and South Asia to use this technology and will be the center of a new agreement to create a global radiosurgery center-of-excellence, specifically the Apollo Brain Center.
Treatments with ZAP-X are expected to begin in early 2023 in New Delhi and then in Mumbai. “With intense research we zeroed in on ZAP-X based on its cutting-edge advantage over historical Cobalt-60 and robotic radiosurgery platforms. With further feedback from our neurosurgeons, we were confident that ZAP-X was the ideal technology to reinforce our standing as a best-in-class provider of neurosurgical care,” said Dr. Prathap Reddy, founder and chairman of Apollo Healthcare, in a statement.
Zap-X’s unique gyroscopic design allows it to apply hundreds of different angled radiation beams to patients. Together, the beams adjust their shape to the contours of the targeted tumor with sub-millimetric precision and are able to avoid hitting critical structures and healthy brain tissue. The treatment also is delivered in one single outpatient procedure, versus five with conventional SRS technologies. In addition, the technology is equipped with a new vault-free design that eliminates the need for costly shielded radiation treatment rooms.
The solution is used in clinical settings worldwide, including at Barrow Neurological Institute in Phoenix, Arizona; MedStar Georgetown Cancer Institute in Clinton, Maryland; and the European Radiosurgery Center in Munich, Germany.
There is even one newly installed
at the Utsunomiya bullet train station in Japan’s Tochigi prefecture. The solution is operated by the Utsunomiya Neurospine Center Symphony Hospital, which offers noninvasive outpatient treatments for many brain tumors that historically required invasive surgical procedures.
It also is a cost-effective alternative that spares patients from having to enter the congested Tokyo city center and crowded nearby hospitals.
More than 30 additional ones are being planned and are in commission stages for installation. Back to HCB News